CN Bio appoints Dr Paul Brooks as Chief Executive Officer

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks, formerly the Company’s Chief Business Officer, to the position of CEO with immediate effect. Former CEO, Dr David Hughes, will continue to work with the company in a consultative role within the Company’s Scientific Advisory Board.

Related Keywords

David Hughes ,David Hughe ,Merck Kga ,Head Of Discovery Research Services ,Company Physiomimix ,Nottingham Business School ,Merck Kgaa ,University Of Manchester Institute Science ,Company Scientific Advisory Board ,Organ Ona Chip Company ,Chief Business Officer ,Scientific Advisory ,Paul Brooks ,Chief Executive Officer ,Image Credit ,Life Science ,Business Operations ,Managing Director ,Horizon Discovery ,Discovery Research Services ,General Manager ,Chief Commercial Officer ,Executive Director ,Oxford Genetics ,Molecular Biology ,Manchester Institute ,Nottingham Business ,Scientific Advisory Board ,Chip ,Research ,